I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bua, Beatriz Rey
62
results:
Search for persons
X
Format
Online (62)
Mediatypes
Articles (Online) (38)
OpenAccess-fulltext (24)
Languages
english (55)
spanish (1)
Sorted by: Year
Sorted by: Relevance
?
1
A research center's experience of T-cell–redirecting therap..:
Puertas, Borja
;
Fernández-Sánchez, Adolfo
;
Alejo, Elena
...
Blood Advances. 8 (2024) 13 - p. 3478-3487 , 2024
Link:
https://doi.org/10.1182/..
?
2
Mass Spectrometry as Alternative Method to Identify and Mon..:
Agulló, Cristina
;
Puig, Noemí
;
Contreras, Teresa
...
Biomedicines. 12 (2024) 6 - p. 1153 , 2024
Link:
https://doi.org/10.3390/..
?
3
Multiple myeloma with t(11;14): impact of novel agents on o..:
Puertas, Borja
;
González-Calle, Verónica
;
Sobejano-Fuertes, Eduardo
...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Novel Agents as Main Drivers for Continued Improvement in S..:
Puertas, Borja
;
González-Calle, Verónica
;
Sobejano-Fuertes, Eduardo
...
Cancers. 15 (2023) 5 - p. 1558 , 2023
Link:
https://doi.org/10.3390/..
?
5
MM-341 Clinical Characteristics and Risk of Progression in ..:
Alejo, Elena
;
Puertas, Borja
;
Agulló, Cristina
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S491 , 2023
Link:
https://doi.org/10.1016/..
?
6
PB2102: IMPACT OF AUTOLOGOUS STEM CELL TRASPLANTATION IN AL..:
Alonso, Elena Alejo
;
Alonso, David
;
Navarro, José María
...
HemaSphere. 7 (2023) S3 - p. e3188025 , 2023
Link:
https://doi.org/10.1097/..
?
7
P-090 Clinical characteristics and risk of progression in p..:
Alejo, Elena
;
Puertas, Borja
;
Agulló, Cristina
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S84 , 2023
Link:
https://doi.org/10.1016/..
?
8
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021:
Lorenzo Juanes, Helena Miriam
;
Carbonell, Cristina
;
Sendra, Begoña Febrer
...
Emerging Infectious Diseases. 29 (2023) 2 - p. 252-259 , 2023
Link:
https://doi.org/10.3201/..
?
9
POSTER: MM-341 Clinical Characteristics and Risk of Progres..:
Alejo, Elena
;
Puertas, Borja
;
Agulló, Cristina
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S218 , 2023
Link:
https://doi.org/10.1016/..
?
10
P-304 Triple class refractory multiple myeloma: eficacy of ..:
Puertas, Borja
;
Alejo, Elena
;
Rey-Bua, Beatriz
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S205-S206 , 2023
Link:
https://doi.org/10.1016/..
?
11
Randomized phase II study of weekly carfilzomib 70 mg/m2 an..:
Puertas, Borja
;
González-Calle, Verónica
;
Sureda, Anna
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
12
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021:
Helena Miriam Lorenzo Juanes
;
Cristina Carbonell
;
Begoña Febrer Sendra
...
https://wwwnc.cdc.gov/eid/article/29/2/22-0677_article. , 2023
Link:
https://doi.org/10.3201/..
?
13
Randomized phase II study of weekly carfilzomib 70 mg/m(2) ..:
Pueras, Borja
;
González-Calle, Verónica
;
Sureda, Anna
...
0390-6078. , 2023
Link:
https://hdl.handle.net/1..
?
14
Novel Agents as Main Drivers for Continued Improvement in S..:
Borja Puertas
;
Verónica González-Calle
;
Eduardo Sobejano-Fuertes
...
https://www.mdpi.com/2072-6694/15/5/1558. , 2023
Link:
https://doi.org/10.3390/..
?
15
Novel Agents as Main Drivers for Continued Improvement in S..:
Borja Puertas
;
Verónica González-Calle
;
Eduardo Sobejano-Fuertes
...
Cancer Therapy. , 2023
Link:
https://doi.org/10.3390/..
1-15